Help
RSS
API
Feed
Maltego
Contact
Domain > 21-cti.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2016-07-15
66.96.149.16
(
ClassC
)
2025-04-02
66.96.149.19
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Sat, 13 Jan 2024 14:55:58 GMTContent-Type: text/htmlContent-Length: 3069Connection: keep-aliveServer: Apache/2X-Powered-By: PHP/5.5.22Age: 0 !DOCTYPE html PUBLIC -//W3C//DTD XHTML 1.0 Transitional//EN http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd>html xmlnshttp://www.w3.org/1999/xhtml>head>link relstylesheet typetext/css hrefstyles.css />link relshortcut icon hrefimages/favicon.png typeimage/x-icon/ >meta http-equivContent-Type contenttext/html; charsetutf-8 />title>21st Century Therapeutics, Inc. | Home/title>/head>body> div idwrapper> div idheader> a hrefindex.php> img srcimages/21-cti.jpg alt21st Century Therapeutics, Inc./>/a> /div>!--Header--> div idnavigation> p classnavigation> a hrefindex.php>HOME/a> | a hrefabout.php>ABOUT/a> | a hrefpublications.php>PUBLICATIONS/a> | a hrefnews.php>NEWS/a> | a hreffcoi.php>FCOI/a> | a hrefcontact.php>CONTACT/a> | strong>a hrefhttp://mail.21-cti.com>21-CTI WEBMAIL/a>/strong> /p> /div>!--Navigation--> div idcontent> h2>21st Century Therapeutics (21 CTI)/h2> p> /p>h3>Chemoprotector/h3>/p> p>UTL-5g is a small-molecule tumor necrosis factor alpha (TNF-a) inhibitor under development as a chemoprotetive agent. This project has received an SBIR Phase I grant and the proposed preclinical studies have been completed satisfactorily./p> p> /p>h3>Radioprotector/h3>/p> p>The Company’s second project is to develop UTL-5g for its potential to reduce lung injury induced by radiation./p> p> /p> p> h3>Natural Products/h3> /p> p>In addition to the leading projects, 21st CTI has several other promising projects. Furthermore, we have over 20,000 extracts from natural products (marine and plants) in stock for screening and we have identified over 100 preliminary leads for secondary screening as potential therapeutic agents./p>/div> !--Content--> div idmission> img srcimages/discovery.jpg altDi
Port 443
HTTP/1.1 200 OKDate: Sat, 13 Jan 2024 14:55:58 GMTContent-Type: text/htmlContent-Length: 3069Connection: keep-aliveServer: Apache/2X-Powered-By: PHP/5.5.22Age: 0 !DOCTYPE html PUBLIC -//W3C//DTD XHTML 1.0 Transitional//EN http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd>html xmlnshttp://www.w3.org/1999/xhtml>head>link relstylesheet typetext/css hrefstyles.css />link relshortcut icon hrefimages/favicon.png typeimage/x-icon/ >meta http-equivContent-Type contenttext/html; charsetutf-8 />title>21st Century Therapeutics, Inc. | Home/title>/head>body> div idwrapper> div idheader> a hrefindex.php> img srcimages/21-cti.jpg alt21st Century Therapeutics, Inc./>/a> /div>!--Header--> div idnavigation> p classnavigation> a hrefindex.php>HOME/a> | a hrefabout.php>ABOUT/a> | a hrefpublications.php>PUBLICATIONS/a> | a hrefnews.php>NEWS/a> | a hreffcoi.php>FCOI/a> | a hrefcontact.php>CONTACT/a> | strong>a hrefhttp://mail.21-cti.com>21-CTI WEBMAIL/a>/strong> /p> /div>!--Navigation--> div idcontent> h2>21st Century Therapeutics (21 CTI)/h2> p> /p>h3>Chemoprotector/h3>/p> p>UTL-5g is a small-molecule tumor necrosis factor alpha (TNF-a) inhibitor under development as a chemoprotetive agent. This project has received an SBIR Phase I grant and the proposed preclinical studies have been completed satisfactorily./p> p> /p>h3>Radioprotector/h3>/p> p>The Company’s second project is to develop UTL-5g for its potential to reduce lung injury induced by radiation./p> p> /p> p> h3>Natural Products/h3> /p> p>In addition to the leading projects, 21st CTI has several other promising projects. Furthermore, we have over 20,000 extracts from natural products (marine and plants) in stock for screening and we have identified over 100 preliminary leads for secondary screening as potential therapeutic agents./p>/div> !--Content--> div idmission> img srcimages/discovery.jpg altDi
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]